Oral Solid Dose CDMOs

Caplin Point Laboratories is a fully integrated Indian pharmaceutical company with a dominant presence in Latin America and Francophone Africa, and a growing presence in the US and EU. Through its subsidiary Caplin Steriles, the company manufactures sterile injectables, ophthalmic products, pre-mix bags, and pre-filled syringes, with 46 FDA-approved products.

Cenra Pharma (formerly CCPC, China Chemical & Pharmaceutical Co.) is a Taiwanese pharmaceutical company established in 1952 that develops and manufactures APIs and generic drugs, also providing CMO/CDMO services. The company has FDA and PMDA facility approvals, PIC/S GMP compliance, and offers services from API selection through formulation development and commercial manufacturing. Cenra specializes in high-potency drugs including immunosuppressants and oncology drugs, with dedicated production lines for penicillins, cephalosporins, carbapenems, and immunosuppressants.

China Resources Zizhu Pharmaceutical Co., Ltd. (CRZP), founded in 1969, is a high-tech pharmaceutical enterprise and subsidiary of China Resources Pharmaceutical. The company manufactures APIs and finished dosage forms including tablets, oral liquids, and topicals, with FDA registration and 5 FDA inspections on record, and 2 FDA-approved products.

CordenPharma is a full-service CDMO providing integrated development and manufacturing of APIs, drug products, and lipid excipients across a global network of cGMP facilities in Europe and North America. The company offers capabilities spanning peptides, oligonucleotides, highly potent and oncology compounds, small molecules, injectables, lipid nanoparticles (LNPs), and oral solid dosage forms. CordenPharma is investing over EUR 500M in a new peptide manufacturing facility in Muttenz, Switzerland, and expanding its Colorado site for large-scale peptide production.

Corealis Pharma Inc. is the same entity as Corealis Pharma, a privately held GMP-compliant CDMO based in Laval, Quebec, Canada. The company specializes in oral solid dosage forms, providing formulation development and cGMP clinical supply manufacturing for Phase I through early Phase III trials. Corealis has expanded its facilities in Laval's Biotech City with an investment of over $10 million and partners with Rottendorf Pharma and Bora Pharmaceuticals for integrated development-to-commercial services.

Dishman Carbogen Amcis Ltd

China

Dishman Carbogen Amcis Ltd is a global CDMO and pharmaceutical outsourcing partner with operations across India, Switzerland, UK, France, Netherlands, and China. With 30 years of experience, they offer custom API development and manufacturing up to 100 metric ton scale, drug product capabilities including highly potent compounds and ADCs, plus finished dosage forms including soft gel capsules and encapsulation. They have received successful USFDA, PMDA, and EDQM inspections.

Domixtar Pharmaceuticals SpA

Italy

Domixtar Pharmaceuticals (DMX Pharma) is Italy's largest CDMO, formed from the merger of Doppel Farmaceutici and Mipharm, and part of the group that includes Alfa Omega for nutraceuticals. With 1,000 professionals serving 105 partners across 30 countries, they offer full-service outsourcing from formulation development through post-marketing, including production, packaging, R&D, logistics, and quality control for pharmaceutical products.

Douglas CDMO

United Kingdom

Douglas CDMO is a division of Douglas Healthcare, an established pharmaceutical company headquartered in New Zealand with a world-class reputation for high standards. The company offers integrated contract development and manufacturing services specializing in high-potency softgels for pharma, biotech, and life science firms.

Eromol UK Ltd (Eramol)

United Kingdom

Eramol (formerly Eromol UK Ltd) is a UK-based CDMO specializing in bespoke clinical trial manufacturing services, founded by two Qualified Persons. The company provides end-to-end services including formulation development, primary manufacturing, clinical packaging, QP release, and global distribution from MHRA and HPRA-approved facilities, with a new sterile injectable site opening in early 2026.

Eskag Global Division (Eskag Pharma)

India

Eskag Pharma is an Indian pharmaceutical manufacturer offering third-party and contract manufacturing services for pharmaceuticals, nutraceuticals, and liposomal products. Founded in 1977, the company has 47+ years of experience and markets 39+ products across 50+ cities with 183 formulations and 50+ DGGI-approved molecules.

Eurofins Biopharma Services (CDMO)

Australia

Eurofins Biopharma Services CDMO is a division of Eurofins Scientific offering integrated API and drug product outsourcing services across small molecules and biologics. The company provides services from early-stage development through commercial manufacturing including highly potent drug development, sterile manufacturing/fill-finish, lyophilization, and biologics development through its Alphora brand.

EUROPHARTECH

France

EUROPHARTECH (Domes Pharma Manufacturing) is a French GMP-certified CMO (Contract Manufacturing Organisation) specializing in the production of small and medium batch pharmaceutical and veterinary products. The company offers oral solid dosage forms (tablets, capsules, powders) and non-sterile liquids for both human and veterinary markets, with a 500m2 QC laboratory equipped with HPLC, UV-visible, IR, and Karl Fischer analyzers.

Euticals (now part of Curia)

France

Euticals, now part of Curia Global, is a global CDMO with over 30 years of experience in drug discovery, development, and manufacturing across small molecules, generic APIs, sterile drug products, and biologics. Curia (which acquired Euticals through AMRI) operates an extensive global network with hundreds of FDA-registered facilities and provides end-to-end services from API manufacturing through sterile fill/finish.

Evonik Industries AG

Canada

Evonik Industries AG is a global specialty chemicals company that operates as a leading CDMO for complex parenteral drug products, focusing on polymeric and lipid-based delivery systems including liposomes, nanoparticles, microparticles, implants, and LNP formulations. The company's Health Care division provides end-to-end CDMO services for small molecules, peptides, nucleic acids (mRNA, siRNA), and HPAPIs, with FDA-inspected facilities in the US and Canada and 34 FDA inspections with zero OAI outcomes.

Exemed Pharmaceuticals

India

Exemed Pharmaceuticals is an Indian pharmaceutical company established in 2009, with US FDA, EDQM, and EU GMP certified manufacturing facilities in Vadodara and Vapi, Gujarat. The company manufactures APIs including Metformin HCL, Allopurinol, Levetiracetam, and Vildagliptin, and also has a finished formulation manufacturing facility acquired from UCB India.

FAMAR

Greece

FAMAR is a leading European pharmaceutical CDMO headquartered in Greece with a network of 7 production sites and 2 R&D centers across Europe, employing approximately 1,800 people. The company provides development, manufacturing, quality, regulatory, and logistics services for a wide range of pharmaceutical and consumer care products across 80+ international markets, with capabilities spanning from oral solid dose to sterile injectables and HPAPI products.

Fareva

Brazil

Fareva is a family-owned French CDMO and the largest in France, employing 13,000 people across 41 production sites in 13 countries with EUR 2.22 billion revenue in 2025. The company provides comprehensive pharmaceutical subcontracting from API manufacturing (including HPAPIs, cytotoxics, hormones, steroids, and controlled substances) to finished drug product manufacturing and packaging across oral, sterile injectable, nasal, ophthalmic, and semi-solid dosage forms.

FarmaTek

Turkey

FarmaTek (Farmatek Ilac San ve Tic A.S.) is a Turkish pharmaceutical company founded in 1991 that transitioned from drug importing to manufacturing, incorporating a hybrid business model including CDMO services. The company operates a GMP-approved production facility in Kirklareli Organized Industrial Zone (approved 2017) and received EU GMP certification in 2021.

Fermion, a wholly owned subsidiary of Orion Corporation (Finland), is a CDMO specializing in developing, manufacturing, and marketing small molecule Active Pharmaceutical Ingredients (APIs), including HPAPIs, cytotoxics, steroids, generics, and controlled substances. Together with its parent Orion, it offers integrated contract development and manufacturing services for both drug substances and drug products, covering the full lifecycle from preclinical to commercial scale. FDA-approved since 1979 and EMA-approved since 1971.

Finecure Pharmaceuticals Limited

India

Finecure Pharmaceuticals Limited is an Indian pharmaceutical formulation company with WHO-GMP certified manufacturing facilities producing oral dosage forms and injections. The company focuses on niche therapeutic segments including cardiovascular, anti-retroviral, neurology, and anti-infectives, with a presence across India and export markets.

Formulated Solutions

United States

Formulated Solutions is a U.S.-based CDMO providing formulation development, analytical development, manufacturing, regulatory affairs, and packaging services for pharmaceutical and consumer health products. The company offers flexible manufacturing from small-scale clinical batches to large-scale commercial production across multiple dosage forms.

FRIULCHEM S.P.A

Italy

FRIULCHEM S.P.A is an Italian CDMO dedicated primarily to animal health, providing contract development and manufacturing of veterinary pharmaceutical products and complementary feeds. The company operates GMP-authorized facilities in Vivaro, Italy and Magny-en-Vexin, France, offering services including micronization, granulation, mixing, spray drying, and packaging, with patented FC-Cubes chewable tablet technology.

Gaelic Laboratories Limited

Ireland

Gaelic Laboratories Limited is an Irish contract manufacturer specializing in Beta-Lactam (penicillin) products in tablet, capsule, and powder for suspension form. Established in 2022 on a site with 40 years of FDA-approved Beta-Lactam manufacturing history, the company serves EU, UK, and MENA markets. The facility spans 8,000 sqm across two GMP manufacturing plants on an 11-acre site, with HPRA licensing.

GENSENTA

Turkey

Gensenta (formerly Mustafa Nevzat Ilac, acquired by Amgen in 2012 and sold to Eczacibasi in 2020) is a vertically integrated Turkish pharmaceutical company with two manufacturing facilities in Yenibosna and Sekerpinar, Turkey. The company manufactures both drug products and raw materials (APIs), and has been recognized in the sterile injectable CDMO market. Gensenta is listed as part of the Eczacibasi group and produces pharmaceuticals including caspofungin.

Getwell Pharma (India) Pvt Ltd

India

Getwell Pharma (India) Pvt Ltd is an Indian pharmaceutical company and a leading player in the oncology finished dosage formulation segment for more than 3 decades. The company manufactures and supplies anti-cancer drugs from its state-of-the-art manufacturing facility. Getwell holds FDA registration and has a global presence across multiple countries.

GMP Laboratories of America, Inc.

United States

GMP Laboratories of America, Inc. is a US-based CDMO providing contract development and manufacturing services for oral solid dosage forms, liquids, semi-solids, and topical products. The company offers formulation development, analytical testing, stability studies, and commercial-scale manufacturing from its FDA-registered facility. It serves pharmaceutical and dietary supplement markets.

Gofarm Sp. z o.o. Sp.k

Poland

Gofarm Sp. z o.o. Sp.k is a Polish CDMO providing contract development and manufacturing services for pharmaceutical products, dietary supplements, and cosmetics. The company offers formulation development, analytical testing, stability studies, and commercial manufacturing for oral solid dosage forms, liquids, and semi-solid products. It operates from EU GMP-compliant facilities in Poland.

Groupe SYNERLAB CDMO

France

Groupe SYNERLAB (now operating as Meribel Pharma Solutions) is a mid-size European CDMO with an integrated network of manufacturing sites across Europe, providing end-to-end services from API manufacturing through finished dosage forms. The company specializes in sterile multidoses, sterile and non-sterile lyophilized products, sachets, stick packs, oral solid dose, liquids, and semi-solids.

Grünenthal PRO (Grünenthal CDMO)

Chile

Duplicate entry of Grunenthal PRO (company ID 8756785b). Grunenthal PRO is the contract manufacturing arm of Grunenthal Group, operating five specialized plants with vertically integrated manufacturing from active substance to finished products. Approximately 50% of total production is for third-party clients across 100+ countries.

Grupo Azevedos (Sofarimex)

Portugal

Grupo Azevedos, operating through its Sofarimex manufacturing unit, is a Portuguese CDMO specializing in freeze-dried injectables and sterile eye drops, with over 20 years of contract manufacturing experience. The company manufactures pharmaceutical medicines and health products for third parties across non-sterile solid, semi-solid, and liquid forms, as well as sterile products, and holds manufacturing licenses from INFARMED and multiple international authorities.

Grupo Medinfar

Portugal

Grupo Medinfar is a Portuguese pharmaceutical company founded in 1970, with an industrial unit that has provided contract manufacturing services for over 20 years. The company manufactures non-sterile solid, semi-solid, and liquid pharmaceutical products for third-party clients, offering turnkey and custom services including bulk manufacturing, packaging, analytical release, and scale-up support.

Huazhong Pharmaceutical Co., Ltd. (HPC) is a Chinese pharmaceutical company established in 1995, manufacturing APIs, intermediates, and finished dosage forms including tablets. The company has GMP manufacturing sites with capabilities in both biological transformations and chemical synthesis, producing products such as albendazole, isoniazid, paracetamol, and nifedipine tablets.

ICE Pharma is a niche API and specialty ingredients CDMO founded in 1949 in Italy, focused on the development and manufacture of bile acid derivatives including Ursodeoxycholic Acid (UDCA). The company operates a fully vertically integrated manufacturing network of 7 global production facilities and provides CDMO services for both APIs and finished dosage forms, as well as custom carbohydrate chemistry through its Dextra unit.

IDI Integratori Dietetici Italiani srl is an Italian pharmaceutical company engaged in the development and manufacturing of pharmaceutical products, dietary supplements, and medical devices. The company has FDA-registered facilities and produces a range of products including tablets, creams, oral solutions, and injectable formulations across multiple therapeutic areas.

ICE Pharma (Industria Chimica Emiliana) is an Italian integrated pharmaceutical company with over 70 years of experience and 1,500 employees worldwide. The company is a leading global producer of Ursodeoxycholic acid (UDCA) and bile acid derivatives, offering CDMO services for solid and liquid finished dosage forms and complex carbohydrates. ICE Pharma operates 7 manufacturing facilities across North and South America, Europe, Asia, and Oceania.

JEWIM Pharmaceutical (Shandong) Co., Ltd. is a Chinese pharmaceutical company in transformation, focusing on innovative drugs and complex drug delivery systems including inhalation products, nasal sprays, and long-acting injectable microspheres. The company is an established CDMO/CMO partner for multinational pharma companies including Johnson & Johnson (Xian Janssen), Kenvue, and Bayer, with quality systems certified by US FDA and Australian TGA. Products are exported to over 80 countries.

KLOCKE GRUPPE

Germany

KLOCKE Gruppe is a leading European contract manufacturer and contract packager of pharmaceuticals, medical devices, and nutritional supplements. They operate through two divisions: KLOCKE Pharma-Service (contract manufacturing of granules, tablets, film-coated tablets, dragees, hard capsules, and sachets) and KLOCKE Verpackungs-Service (contract packaging into cold and thermoformed blisters, bottles, and liquid filling). With 750 employees worldwide, over 60 years of family tradition, ~3,000 product items, and ~EUR 140M revenue, they are one of the largest pharmaceutical contract packagers in Europe. FDA-registered (3 FEI numbers) with operations in Germany.

Labialfarma

Portugal

Labialfarma is a Portuguese CDMO established in 1981, specializing in the development and contract manufacturing of nutraceuticals, medicines, cosmetics, medical devices, and complementary feed products. They serve over 15 million people worldwide annually. Their capabilities span solid, semi-solid, and liquid dosage forms, with proprietary technologies including flavoring, sealed benefit protection, rapid disintegration, and SmartPACKAGING innovations. They offer end-to-end services from formulation development to finished product packaging. Labialfarma is primarily focused on the nutraceutical/food supplement space rather than prescription pharmaceuticals.

LABOMAR S.P.A.

Italy

LABOMAR S.p.A. is an Italian CDMO with 25+ years of experience, specializing in the research, development, and contract manufacturing of innovative food supplements, medical devices, foods for special medical purposes, and cosmetics. The company is a portfolio company of Charterhouse Capital Partners. LABOMAR operates as a one-stop-shop CDMO producing solid, liquid, and semi-solid dosage forms. They have expanded internationally through acquisitions including Finnish company Pharmia and Canadian company ImportFab. LABOMAR is a Certified B Corporation and primarily serves the nutraceutical rather than prescription pharmaceutical market.

Lavipharm

Greece

Lavipharm is a dynamic, international healthcare company listed on the Athens Stock Exchange since 1995, based in Greece. Their manufacturing plant is one of the few pharmaceutical manufacturing sites in Europe with fully integrated production lines, including dedicated lines for transdermal drug delivery systems (TDDS). The production facility covers 8,000 m2 and produces tablets, capsules, transdermal systems, oral liquids, creams, and ointments under strict GMP conditions. Lavipharm collaborates with FAMAR for contract manufacturing and has launched the first locally produced medical cannabis prescription product in Greece. They also partner with other companies for manufacturing services.

Lee Pharma Limited

India

Lee Pharma Limited is an Indian pharmaceutical company established in 1997 in Hyderabad, focused on the development, synthesis, and commercialization of Active Pharmaceutical Ingredients (APIs), intermediates, semi-finished dosage forms (pellets and granules), and finished formulations. Manufacturing facilities are approved by USFDA, EUGMP, and WHO GMP. Listed on CPHI Online as a CMO/CDMO and manufacturer. Serves partners in 30+ countries with a focus on Europe and Asia. Also has a CDMO services page and offers contract manufacturing services.

Lupin Limited (Lupin Manufacturing Solutions)

Brazil

Lupin Manufacturing Solutions (LMS) is the CDMO arm of Lupin Limited, one of India's largest pharmaceutical companies. LMS offers integrated CDMO services spanning API manufacturing, formulation development, and finished dosage form production. They operate 16 FDA-registered facilities with 512 FDA-approved products. They have recently expanded into oncology with a dedicated block at Vizag, India, and formed a strategic alliance with PolyPeptide for peptide supply chain scaling. Their extensive regulatory track record includes FDA, WHO, and multiple international approvals.

Mapaex Consumer Healthcare Private Limited

India

Mapaex Consumer Healthcare Private Limited is an Indian contract manufacturer and CDMO specializing in Oral Care, Personal Care, Consumer Healthcare, and Vitamin & Mineral supplements. The company provides end-to-end services from ingredient sourcing through product development, manufacturing, packaging, compliance, and supply chain management. Mapaex also offers white label and private label manufacturing services. The company is focused on consumer healthcare products rather than prescription pharmaceuticals.

Marifarm proizvodnja in storitve d.o.o.

Slovenia

Marifarm d.o.o. is a Slovenian pharmaceutical company providing contract manufacturing services including finished dosage form manufacturing, project management, analytical services, logistics (GDP certified), herbal extract production, serialization systems, and microbiological quality control. The company is listed in pharmaceutical CMO industry databases and serves as a contract manufacturing partner for finished pharmaceutical products.

Mipharm S.p.A

Italy

Mipharm S.p.A. is a Milan-based pharmaceutical CDMO and one of the largest pharma CDMO sites in Italy. The company specializes in contract development and manufacturing of pharmaceutical products including production, packaging, R&D, and clinical trial logistics. 20% of staff is dedicated to quality. FDA-inspected (6 inspections, 1 NAI, 5 VAI).

Montage Laboratories Private Limited

India

Montage Laboratories Private Limited is an Indian pharmaceutical formulations manufacturer based in Himatnagar, Gujarat with 30+ years of experience. The company specializes in sex hormone formulations and injectables, with dedicated facilities for sex hormone injection manufacturing (ampoules, vials, pre-filled syringes) and both beta-lactam and general injectable production. FDA-registered with 3 FEI numbers and 14 FDA inspections (12 NAI, 2 VAI — excellent track record). ISO 9001:2015 and ISO 14001:2015 certified, D&B certified.

Murli Krishna Pharma Pvt Ltd

India

Duplicate entry for Murli Krishna Pharma Private Ltd. (mkppl.com) - same company, same website domain. Indian pharmaceutical CDMO specializing in PFI and FDF products with CRAMS services.

Norwich Pharmaceuticals (now Norwich Pharma Services, part of Alvogen) is a US-based contract development and manufacturing organization with over 130 years of pharmaceutical manufacturing history in Norwich, New York. The company manufactures generic medications including capsules, tablets, and extended-release tablets. Norwich is FDA-registered with operations including analysis, labeling, manufacturing, packing, relabeling, and repacking, and has 3 FDA-approved products with strong inspection history (6 NAI out of 7).